Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Spironolactone on Acute Kidney Injury in Patients Undergoing Coronary Angiography

NCT03329443 is registered in ClinicalTrials.gov with Alhasan Mujtaba Abdul-Wahid as lead sponsor.

NCT NCT03329443
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03329443 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Spironolactone on Acute Kidney Injury in Patients Undergoing Coronary Angiography
Lead sponsor
Alhasan Mujtaba Abdul-Wahid
Phase
Phase 2
Overall status
Completed
Start date
September 1, 2017
Completion date
September 4, 2018
Enrollment
490 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute kidney injury, contrast-induced nephropathy, ihd